首页>投融资

Zucara Therapeutics

B轮

Zucara Therapeutics Inc is a spin-off of the Centre for Drug Research and Development and MaRS Innovation , is a company involved in a novel drug therapy to treat diabetes.In November 2016, the company recieved US $525,000 investment from Accel-Rx Health Sciences Accelerator, The Centre for Drug Research and Development (CDRD) and MaRS Innovation.In September 2022, Zucara Therapeutics Inc announced that its positive proof-of-concept data has enabled the Company to secure continued funding for a Phase 2 clinical study of ZT-01

http://www.zucara.ca/

470178

基本信息

公司全称

Zucara Therapeutics Inc
类型

新药研发商
产业领域

药品研发/制造、医药研发/制造、化学药
公司人数

15人以下
地址

1300-661 University Avenue TORONTO ONTARIO M5G 0B7; CA;
联系电话

+1 604-432-2151
邮箱
成立时间

2015-01-01

投融资

2024-11-12

B轮

2000万美元

赛诺菲
2023-06-15

捐赠/众筹/授予

未透露

JDRF
2022-05-02

捐赠/众筹/授予

未透露

Mitacs

GlycoNet
2020-03-31

A轮

2100万美元

Perceptive Advisors
2019-07-12

未透露

6.9万美元

GlycoNet
2018-04-09

未透露

390万美元

The Leona M. and Harry B. Helmsley Charitable Trust
2018-02-08

未透露

35万美元

Centre for Drug Research and Development

Toronto Innovation Acceleration Partners

National Research Council of Canada Industrial Research Assistance Program
2017-09-21

未透露

未透露

未透露
加载更多

Zucara Therapeutics

基本信息

投融资

相关投融资企业